{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:02:24Z","timestamp":1790946144817,"version":"4.1.0"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science, Research, and Innovation Fund (NSRF) and Prince of Songkla University","award":["MET6601063S"],"award-info":[{"award-number":["MET6601063S"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Chronic myeloid leukemia (CML) is a hematologic malignancy originating from hematopoietic stem cells and driven by the BCR-ABL fusion oncogene. Imatinib (IM), a tyrosine kinase inhibitor, is commonly used as a frontline therapy for CML. However, some patients exhibit primary resistance or show persistent molecular evidence of disease despite treatment. Emerging studies indicate that exosome-derived microRNAs (miRNAs) play a role in mediating drug resistance and may serve as promising biomarkers for cancer diagnosis and predicting therapeutic response. This study aimed to investigate the plasma exosomal miRNA expression profiles in CML patients to identify potential biomarkers associated with IM resistance. Exosomes were isolated from plasma samples of both IM-sensitive and IM-resistant CML patients. The exosomal miRNA content was analyzed using RNA sequencing, followed by differential expression analysis, which revealed 13 upregulated and 21 downregulated miRNAs in IM-resistant patients. Subsequent bioinformatics analysis indicated significant enrichment in pathways related to autophagy and PI3K-Akt signaling. Notably, miR-451a and miR-16\u20132-3p were among the most significantly upregulated miRNAs in exosomes from IM-resistant individuals. Interestingly, miR-16\u20132-3p expression showed a strong inverse correlation with clinical laboratory results, specifically blood urea nitrogen and creatinine levels. This pilot study identified plasma exosomal miRNAs, particularly miR-451a and miR-16\u20132-3p, as potential biomarkers for imatinib resistance in chronic myeloid leukemia. Target gene prediction was performed to explore their regulatory roles. Despite the limited sample size, these findings enhance our understanding of drug resistance mechanisms and warrant further validation in larger cohorts to assess their clinical relevance and therapeutic potential.<\/jats:p>","DOI":"10.1371\/journal.pone.0331479","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T17:38:23Z","timestamp":1756489103000},"page":"e0331479","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exosomal miRNA expression profiling in patients with imatinib resistant Chronic myeloid leukemia: A pilot study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6408-0079","authenticated-orcid":true,"given":"Raphatphorn","family":"Navakanitworakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirun","family":"Saelue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tipparat","family":"Penglong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyatida","family":"Molika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-613X","authenticated-orcid":true,"given":"Natakorn","family":"Nokchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natta","family":"Tansila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansuk","family":"Buncherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supinya","family":"Thanapongpichat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1806-2544","authenticated-orcid":true,"given":"Kanitta","family":"Srinoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"14","key":"pone.0331479.ref001","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM200104053441409","article-title":"Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"JM Goldman","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0331479.ref002","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: stemming the tide of persistence","volume":"129","author":"TL Holyoake","year":"2017","journal-title":"Blood"},{"issue":"3","key":"pone.0331479.ref003","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"R Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"pone.0331479.ref004","doi-asserted-by":"crossref","first-page":"1239042","DOI":"10.3389\/fonc.2023.1239042","article-title":"Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules","volume":"13","author":"S Bernardi","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0331479.ref005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12185-008-0230-0","article-title":"Chronic myeloid leukemia in Asia","volume":"89","author":"WY Au","year":"2009","journal-title":"Int J Hematol"},{"issue":"4","key":"pone.0331479.ref006","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1182\/blood-2006-06-031682","article-title":"The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia","volume":"109","author":"VG Oehler","year":"2007","journal-title":"Blood"},{"issue":"23","key":"pone.0331479.ref007","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"BJ Druker","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0331479.ref008","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"JF Apperley","year":"2007","journal-title":"Lancet Oncol"},{"issue":"10","key":"pone.0331479.ref009","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia","volume":"376","author":"A Hochhaus","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0331479.ref010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cancergencyto.2004.09.021","article-title":"BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib","volume":"159","author":"D Gadzicki","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"pone.0331479.ref011","doi-asserted-by":"crossref","first-page":"779567","DOI":"10.3389\/fonc.2021.779567","article-title":"Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients","volume":"11","author":"M-Y Li","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"pone.0331479.ref012","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3892\/ijo.2020.5163","article-title":"Exosomes released by imatinib\u2011resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib\u2011sensitive cells in the presence of imatinib","volume":"58","author":"T Hrdinova","year":"2021","journal-title":"Int J Oncol"},{"key":"pone.0331479.ref013","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semcancer.2021.03.014","article-title":"miRNAs mediated drug resistance in hematological malignancies","volume":"83","author":"S Peixoto da Silva","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"pone.0331479.ref014","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3892\/or.2015.4456","article-title":"The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review)","volume":"35","author":"C Di Stefano","year":"2016","journal-title":"Oncol Rep"},{"issue":"10","key":"pone.0331479.ref015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41419-021-04209-2","article-title":"Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance","volume":"12","author":"Y-Y Wu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"15","key":"pone.0331479.ref016","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.3390\/ijms23158827","article-title":"Extracellular Vesicles in Myeloid Neoplasms","volume":"23","author":"C Karantanou","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0331479.ref017","doi-asserted-by":"crossref","first-page":"1265969","DOI":"10.3389\/fimmu.2023.1265969","article-title":"Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment","volume":"14","author":"D Van Morckhoven","year":"2023","journal-title":"Front Immunol"},{"issue":"17","key":"pone.0331479.ref018","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.3390\/ijms231710118","article-title":"Extracellular Vesicles in Haematological Disorders: A Friend or a Foe?","volume":"23","author":"I Lazana","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0331479.ref019","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"30","key":"pone.0331479.ref020","article-title":"Chimeric apoptotic bodies functionalized with natural membrane and modular delivery system for inflammation modulation","volume":"6","author":"G Dou","year":"2020","journal-title":"Sci Adv"},{"issue":"6","key":"pone.0331479.ref021","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"H Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"pone.0331479.ref022","doi-asserted-by":"crossref","first-page":"101975","DOI":"10.1016\/j.ctrv.2020.101975","article-title":"The role of exosomes in metastasis and progression of melanoma","volume":"85","author":"R Gowda","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"pone.0331479.ref023","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fonc.2020.00090","article-title":"Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment","volume":"10","author":"J Nehrbas","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0331479.ref024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-019-0965-7","article-title":"Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance","volume":"18","author":"S Maacha","year":"2019","journal-title":"Mol Cancer"},{"issue":"4","key":"pone.0331479.ref025","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/cells9041044","article-title":"Sorting Mechanisms for MicroRNAs into Extracellular Vesicles and Their Associated Diseases","volume":"9","author":"M Groot","year":"2020","journal-title":"Cells"},{"issue":"2","key":"pone.0331479.ref026","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.yexcr.2017.12.001","article-title":"Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365","volume":"362","author":"Q-H Min","year":"2018","journal-title":"Exp Cell Res"},{"key":"pone.0331479.ref027","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.canlet.2014.10.006","article-title":"MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein","volume":"356","author":"O Hershkovitz-Rokah","year":"2015","journal-title":"Cancer Lett"},{"issue":"2","key":"pone.0331479.ref028","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2014.03.049","article-title":"Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR\/ABL positive CML patients","volume":"542","author":"D Joshi","year":"2014","journal-title":"Gene"},{"issue":"12","key":"pone.0331479.ref029","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1007\/s00210-024-03198-1","article-title":"Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia","volume":"397","author":"AZ Karabay","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"pone.0331479.ref030","first-page":"100529","article-title":"Impact of non-coding RNAs on resistance to imatinib in chronic myelogenous leukemia","volume":"24","author":"F Ensafi Talemi","year":"2025","journal-title":"Leuk Res Rep"},{"issue":"4","key":"pone.0331479.ref031","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"A Hochhaus","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"pone.0331479.ref032","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"M Baccarani","year":"2013","journal-title":"Blood"},{"key":"pone.0331479.ref033","first-page":"149","article-title":"Statistical methods for identifying differentially expressed genes in DNA microarrays","volume":"224","author":"JD Storey","year":"2003","journal-title":"Methods Mol Biol"},{"key":"pone.0331479.ref034","article-title":"KEGG for linking genomes to life and the environment","volume":"36","author":"M Kanehisa","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"pone.0331479.ref035","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"M Kanehisa","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"pone.0331479.ref036","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1093\/bioinformatics\/bti430","article-title":"Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary","volume":"21","author":"X Mao","year":"2005","journal-title":"Bioinformatics"},{"issue":"1","key":"pone.0331479.ref037","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"BP Lewis","year":"2005","journal-title":"Cell"},{"key":"pone.0331479.ref038","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Y Chen","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"pone.0331479.ref039","article-title":"miRTarBase: a database curates experimentally validated microRNA-target interactions","volume":"39","author":"S-D Hsu","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0331479.ref040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbcan.2018.07.003","article-title":"Extracellular vesicles and anti-cancer drug resistance","volume":"1870","author":"NM Namee","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"pone.0331479.ref041","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3389\/fonc.2020.00960","article-title":"Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance","volume":"10","author":"X Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"6","key":"pone.0331479.ref042","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/ijms18061183","article-title":"Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy","volume":"18","author":"A Caivano","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"8","key":"pone.0331479.ref043","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3390\/cancers15082307","article-title":"Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?","volume":"15","author":"K Dubois","year":"2023","journal-title":"Cancers (Basel)"},{"key":"pone.0331479.ref044","doi-asserted-by":"crossref","first-page":"860849","DOI":"10.3389\/fonc.2022.860849","article-title":"Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study","volume":"12","author":"BV Ferreira","year":"2022","journal-title":"Front Oncol"},{"key":"pone.0331479.ref045","doi-asserted-by":"crossref","first-page":"909880","DOI":"10.3389\/fimmu.2022.909880","article-title":"Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment","volume":"13","author":"R Lopes","year":"2022","journal-title":"Front Immunol"},{"issue":"23","key":"pone.0331479.ref046","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.2021014749","article-title":"Exosomes in multiple myeloma: from bench to bedside","volume":"140","author":"E Menu","year":"2022","journal-title":"Blood"},{"issue":"6","key":"pone.0331479.ref047","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1039\/D2NA00959E","article-title":"The potential role of serum extracellular vesicle derived small RNAs in AML research as non-invasive biomarker","volume":"5","author":"L Li","year":"2023","journal-title":"Nanoscale Adv"},{"issue":"8","key":"pone.0331479.ref048","article-title":"Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers","volume":"19","author":"K-W Kang","year":"2024","journal-title":"PLoS One"},{"issue":"8","key":"pone.0331479.ref049","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/leu.2012.65","article-title":"Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells","volume":"26","author":"Y Yu","year":"2012","journal-title":"Leukemia"},{"key":"pone.0331479.ref050","doi-asserted-by":"crossref","first-page":"102043","DOI":"10.1016\/j.ctrv.2020.102043","article-title":"The role of autophagy in resistance to targeted therapies","volume":"88","author":"L Mele","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"pone.0331479.ref051","doi-asserted-by":"crossref","first-page":"1394140","DOI":"10.3389\/fcell.2024.1394140","article-title":"Progress in the study of autophagy-related proteins affecting resistance to chemotherapeutic drugs in leukemia","volume":"12","author":"M Li","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"pone.0331479.ref052","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3892\/ijo.2014.2313","article-title":"Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia","volume":"44","author":"S Shao","year":"2014","journal-title":"Int J Oncol"},{"issue":"11","key":"pone.0331479.ref053","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/nsmb.2678","article-title":"Analysis of microRNA-target interactions across diverse cancer types","volume":"20","author":"A Jacobsen","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"pone.0331479.ref054","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-8-69","article-title":"MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations","volume":"8","author":"E San Jos\u00e9-En\u00e9riz","year":"2009","journal-title":"Mol Cancer"},{"key":"pone.0331479.ref055","first-page":"100257","article-title":"Circulating miRNAs can serve as potential diagnostic biomarkers in chronic myelogenous leukemia patients","volume":"16","author":"F Keramati","year":"2021","journal-title":"Leuk Res Rep"},{"issue":"7","key":"pone.0331479.ref056","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2217\/fon-2018-0741","article-title":"Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases","volume":"15","author":"J Zhang","year":"2019","journal-title":"Future Oncol"},{"issue":"4","key":"pone.0331479.ref057","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10245332.2016.1252020","article-title":"Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance","volume":"22","author":"I Soltani","year":"2017","journal-title":"Hematology"},{"issue":"7","key":"pone.0331479.ref058","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.leukres.2011.03.029","article-title":"MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?","volume":"35","author":"T Lopotov\u00e1","year":"2011","journal-title":"Leuk Res"},{"issue":"3","key":"pone.0331479.ref059","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.23381","article-title":"MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes","volume":"51","author":"C Braconi","year":"2010","journal-title":"Hepatology"},{"issue":"11","key":"pone.0331479.ref060","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101566118","article-title":"Loss of expression of both miR-15\/16 loci in CML transition to blast crisis","volume":"118","author":"F Lovat","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pone.0331479.ref061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024145","article-title":"Haemolysis during sample preparation alters microRNA content of plasma","volume":"6","author":"MB Kirschner","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"pone.0331479.ref062","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3892\/ijo.2021.5242","article-title":"Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review)","volume":"59","author":"Y Luo","year":"2021","journal-title":"Int J Oncol"},{"issue":"1","key":"pone.0331479.ref063","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41420-024-01924-5","article-title":"Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia","volume":"10","author":"C Spertini","year":"2024","journal-title":"Cell Death Discov"},{"issue":"1","key":"pone.0331479.ref064","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/s12885-022-09725-8","article-title":"MIF\/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment","volume":"22","author":"L Garcia-Gerique","year":"2022","journal-title":"BMC Cancer"},{"issue":"4","key":"pone.0331479.ref065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jclinpath-2016-203972","article-title":"Expression pattern of miR-451 and its target MIF (macrophage migration inhibitory factor) in colorectal cancer","volume":"70","author":"A Mamoori","year":"2017","journal-title":"J Clin Pathol"},{"issue":"4","key":"pone.0331479.ref066","first-page":"312","article-title":"MiR-451 regulates proliferation and migration of colorectal cells by targeting MIF","volume":"42","author":"YG Ma","year":"2020","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"8","key":"pone.0331479.ref067","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrm2728","article-title":"Rab GTPases as coordinators of vesicle traffic","volume":"10","author":"H Stenmark","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"pone.0331479.ref068","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4161\/auto.29395","article-title":"The autophagic roles of Rab small GTPases and their upstream regulators: a review","volume":"10","author":"Z Szatm\u00e1ri","year":"2014","journal-title":"Autophagy"},{"issue":"1","key":"pone.0331479.ref069","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10565-024-09866-5","article-title":"Function and regulation of Rab GTPases in cancers","volume":"40","author":"S Xu","year":"2024","journal-title":"Cell Biol Toxicol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0331479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T17:38:33Z","timestamp":1756489113000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0331479"}},"subtitle":[],"editor":[{"given":"Mohammad H.","family":"Ghazimoradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0331479","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}